Correlation Between Enzo Biochem and Star Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and Star Equity Holdings, you can compare the effects of market volatilities on Enzo Biochem and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and Star Equity.

Diversification Opportunities for Enzo Biochem and Star Equity

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Enzo and Star is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and Star Equity go up and down completely randomly.

Pair Corralation between Enzo Biochem and Star Equity

Considering the 90-day investment horizon Enzo Biochem is expected to under-perform the Star Equity. But the stock apears to be less risky and, when comparing its historical volatility, Enzo Biochem is 1.03 times less risky than Star Equity. The stock trades about -0.3 of its potential returns per unit of risk. The Star Equity Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  216.00  in Star Equity Holdings on November 2, 2024 and sell it today you would lose (1.00) from holding Star Equity Holdings or give up 0.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Enzo Biochem  vs.  Star Equity Holdings

 Performance 
       Timeline  
Enzo Biochem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Star Equity Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Star Equity Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Enzo Biochem and Star Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzo Biochem and Star Equity

The main advantage of trading using opposite Enzo Biochem and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.
The idea behind Enzo Biochem and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals